Clinical Trial Update: Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating reslizumab in severe asthma patients who failed to respond to omalizumab has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• reslizumab (reslizumab)

Snippet

Sponsor: Sociedad Española de Neumología y Cirugía Torácica | Conditions: Severe Asthma | Phase 2 | Status: COMPLETED